Critical Contrast: Sonic Healthcare (OTCMKTS:SKHHY) and Qiagen (NYSE:QGEN)

Sonic Healthcare (OTCMKTS:SKHHYGet Free Report) and Qiagen (NYSE:QGENGet Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Analyst Recommendations

This is a breakdown of current recommendations for Sonic Healthcare and Qiagen, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonic Healthcare 0 0 1 0 3.00
Qiagen 0 3 5 0 2.63

Qiagen has a consensus price target of $51.99, suggesting a potential upside of 19.08%. Given Qiagen’s higher probable upside, analysts plainly believe Qiagen is more favorable than Sonic Healthcare.

Valuation & Earnings

This table compares Sonic Healthcare and Qiagen’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sonic Healthcare N/A N/A N/A N/A N/A
Qiagen $2.14 billion 4.65 $423.21 million $1.45 30.11

Qiagen has higher revenue and earnings than Sonic Healthcare.

Profitability

This table compares Sonic Healthcare and Qiagen’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sonic Healthcare N/A N/A N/A
Qiagen 17.01% 13.15% 7.60%

Institutional & Insider Ownership

58.0% of Qiagen shares are owned by institutional investors. 9.0% of Qiagen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Qiagen beats Sonic Healthcare on 8 of the 9 factors compared between the two stocks.

About Sonic Healthcare

(Get Free Report)

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

About Qiagen

(Get Free Report)

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.